Five-year safety and performance data of a novel third-generation novolimus-eluting bioresorbable scaffold in single de novo lesions

EuroIntervention. 2019 Oct 20;15(8):685-687. doi: 10.4244/EIJ-D-18-00292.
No abstract available

MeSH terms

  • Absorbable Implants*
  • Biocompatible Materials / therapeutic use*
  • Coronary Artery Disease / therapy*
  • Coronary Stenosis / drug therapy*
  • Coronary Stenosis / surgery
  • Drug-Eluting Stents*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Macrolides / therapeutic use*
  • Percutaneous Coronary Intervention*
  • Treatment Outcome

Substances

  • Biocompatible Materials
  • Immunosuppressive Agents
  • Macrolides
  • novolimus